LeafNLP Demos
Back to explore

Report #2865538

Received Oct 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
60 yrs
State
NJ
Recovered
Unknown
Vaccinated
Sep 2, 2025
Onset
Sep 2, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2PJ353—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

got by accident an early second dose of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number PJ353, expiry date 31-MAR-2027) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). On 02-SEP-2025, the patient received the 2nd dose of Shingrix. On 02-SEP-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: got by accident an early second dose of Shingrix). The outcome of the drug dose administration interval too short was not applicable.

Other medications

SHINGRIX